Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer

Схожі ресурси

• Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer
  за авторством: Daniele Generali, та інші
  Опубліковано: (2006)
• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
  за авторством: Fox, Stephen B, та інші
  Опубліковано: (2011)
• Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer
  за авторством: Daniele Generali, та інші
  Опубліковано: (2008)
• Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer
  за авторством: Bottini, A, та інші
  Опубліковано: (2003)
• Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
  за авторством: Daniele Generali, та інші
  Опубліковано: (2009)